Company Filing History:
Years Active: 2013-2015
Title: George R Simon: Innovator in Oncological Research
Introduction
George R Simon is a notable inventor based in Huntingdon Valley, PA (US). He has made significant contributions to the field of oncological research, holding 2 patents that focus on innovative treatments for cancer. His work aims to improve patient outcomes and provide new strategies for managing oncological disorders.
Latest Patents
One of Simon's latest patents is titled "Oncotherapeutic application of inhibitors of high-affinity glucose transporters." This invention concerns materials and methods for treating oncological disorders in a person or animal by using agents or compounds that inhibit glucose uptake into cells. The methods also involve inducing apoptosis and inhibiting the proliferation or survival of cells. In one embodiment, the methods include administering an effective amount of an agent that inhibits the activity of glucose transporter proteins, such as Glut-1. An antibody that binds to and inhibits a glucose transporter protein can be utilized in these methods.
Another significant patent is "Predictive value of nuclear excision repair genes for cancer survival." This research highlights that patients who have undergone surgical removal of cancer are at risk for recurrence, even when currently disease-free. The study found that lung cancer patients with higher activity of a nuclear excision repair gene called ERCC1 had a lower risk of recurrence compared to those with lower activity. This information can be instrumental in predicting which patients are at a higher risk for recurrence after resection, allowing for tailored treatment strategies.
Career Highlights
George R Simon is affiliated with the University of South Florida, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to change the landscape of oncological therapies and improve patient care.
Collaborations
Simon collaborates with Gerold Bepler, a prominent figure in the field. Their partnership aims to enhance research efforts and develop innovative solutions for cancer treatment.
Conclusion
George R Simon's contributions to oncological research through his patents and collaborations highlight his commitment to improving cancer treatment strategies. His innovative approaches have the potential to significantly impact patient outcomes in the field of oncology.